Brigatinib Activity in Patients with ALK plus NSCLC and Intracranial CNS Metastases in Two Clinical Trials
- Authors
- Gettinger, S[Gettinger, Scott]; Kim, DW[Kim, Dong-Wan]; Tiseo, M[Tiseo, Marcello]; Langer, C[Langer, Corey]; Ahn, MJ[Ahn, Myung-Ju]; Shaw, A[Shaw, Alice]; Huber, R[Huber, Rudolf]; Hochmair, M[Hochmair, Maximilian]; Kim, SW[Kim, Sang-We]; Bazhenova, L[Bazhenova, Lyudmila]; Gold, K[Gold, Kathryn]; Ou, SH[Ou, Sai-Hong]; West, H[West, Howard]; Reichmann, W[Reichmann, William]; Haney, J[Haney, Jeff]; Clackson, T[Clackson, Tim]; Haluska, F[Haluska, Frank]; Kerstein, D[Kerstein, David]; Camidge, DR[Camidge, D. Ross]
- Issue Date
- Jan-2017
- Publisher
- ELSEVIER SCIENCE INC
- Keywords
- NSCLC; TKI; ALK; brigatinib
- Citation
- JOURNAL OF THORACIC ONCOLOGY, v.12, no.1, pp.S273 - S274
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF THORACIC ONCOLOGY
- Volume
- 12
- Number
- 1
- Start Page
- S273
- End Page
- S274
- URI
- https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/30571
- DOI
- 10.1016/j.jtho.2016.11.271
- ISSN
- 1556-0864
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.